A Science and Technology Blog
ICMR’s insistence on an evidence-based approach to plasma therapy is a welcome change and is in stark contrast to the cavalier manner in which it approved hydroxychloroquine as a prophylaxis…
A pharma company in China is testing convalescent plasma therapy to treat critically sick COVID-19 patients. So far, 13 patients have been treated and some improvements in clinical symptoms have…
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high as 90% if patients are treated with one of the…
Merck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in preventing Ebola disease when used during the current epidemic in…
On July 17, the WHO finally declared Ebola virus disease outbreak in Congo a Public Health Emergency of International Concern. Since the beginning of the outbreak in August 2018, Ebola…
Days after the WHO declared the end of the May 8 Ebola outbreak in the Democratic Republic of the Congo, a fresh outbreak was reported on August 1 in North Kivu. If…
On the health front, the year 2016 witnessed a few setbacks and but also a few positive developments. Here are the most important health developments of 2016 1. Trial results…
The first Phase-1 human clinical trial of a vaccine for Zika virus is set to begin in the coming weeks, with the U.S. Food and Drug Administration (FDA) green-lighting it. The…
